Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06527456

Intervention With General Practitioners to Improve Women's Participation in Cervical Cancer Screening

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
11,200 (estimated)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In France, cervical cancer is the 12th most common female cancer with nearly 3,000 new cases per year. Since 2018, a national Organized Cervical Cancer Screening program (DOCCU) has been set up and concerns all asymptomatic women aged 25 to 65. This program, managed by the Regional Cancer Screening Coordination Centers (CRCDC), invites women who have not taken a sample within the recommended time frame to consult for screening. However, only 59% of patients participated. The intervention of the general practitioner, an essential player in prevention, could allow for better awareness. The objective of the INDIGO study is to evaluate the effectiveness of the intervention of a general practitioner on the participation rate in the DOCCU of patients who are not up to date with their screening.

Detailed description

This is a cluster-randomized trial. Randomization will be performed at the GP practice level to limit the potential contamination bias between doctors within the same practice. GP practices will be randomized either to the 'usual practice' arm or the 'intervention' arm." If they are in the "intervention" group, they or one of the professionals in their team will contact the patient (phone call, SMS, email, etc.), to encourage her to make an appointment to carry out the screening. Contact arrangements are left to the discretion of each general practitioner.. If they are in the "Usual practice" group, they will use their usual practices to encourage screening.

Conditions

Interventions

TypeNameDescription
OTHERparticipation of the general practitionerparticipation of the general practitioner in encouraging cervical cancer screening

Timeline

Start date
2026-01-21
Primary completion
2027-08-01
Completion
2027-08-01
First posted
2024-07-30
Last updated
2026-04-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06527456. Inclusion in this directory is not an endorsement.